Archi Rungta, Medical Research Fellow at Cancer Genetics Clinic MPMMCC VNS, shared on LinkedIn:
“We are pleased to share our latest editorial published in the International Journal of Molecular and Immuno Oncology.
‘The Microbiome: A New Frontier in Cancer Immunotherapy – From Mechanistic Insights to Clinical Translation’
This article explores how the gut microbiome influences anti-tumor immunity and the response to immune checkpoint inhibitors, highlighting the growing role of microbial signatures as potential biomarkers in precision oncology.
As cancer treatment continues to evolve, understanding the interaction between the microbiome and the immune system may help us develop more personalized and effective therapeutic strategies.
Special thanks to Akhil Kapoor for giving me this opportunity.
Always grateful for his guidance and collaboration.
Link to full article: The microbiome: A new frontier in cancer immunotherapy – From mechanistic insights to clinical translation.”
Other articles about microbiome on OncoDaily.